These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 3915581)

  • 1. [Effect of long-term hydralazine in dilated myocardiopathies].
    Dighero H; Zepeda F; Gómez G
    Rev Med Chil; 1985 Sep; 113(9):844-9. PubMed ID: 3915581
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined use of isoprenaline and hydralazine in the treatment of chronic circulatory insufficiency].
    Krzyś T; Kalawski R; Flaczyński K; Lenartowicz I
    Wiad Lek; 1985 Jan; 38(2):97-101. PubMed ID: 4002707
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemodynamic and neurohumoral response to hydralazine versus captopril: a controlled study in idiopathic dilated cardiomyopathy.
    Schofer J; Mathey DG; Polster J; Bode V; Dietlein G
    J Cardiovasc Pharmacol; 1987; 9 Suppl 2():S46-9. PubMed ID: 2441201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute hemodynamic effect of verapamil, used intravenously, in patients with primary dilated cardiomyopathy].
    Manfroi WC; Ludwig RT; Vieira SR; Goldim JR; Das SK; de Freitas FM; Faraco EZ
    Arq Bras Cardiol; 1985 Nov; 45(5):371-5. PubMed ID: 3915860
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical administration of hydralazin (Depressan) in essential and renal hypertension].
    Teichmann G; Harms R; Wedler B; Rohmann H
    Z Arztl Fortbild (Jena); 1972 Nov; 66(21):1112-6. PubMed ID: 4576549
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral hydralazine therapy for acute pulmonary embolism and low output state.
    Bates ER; Crevey BJ; Sprague FR; Pitt B
    Arch Intern Med; 1981 Oct; 141(11):1537-8. PubMed ID: 7283569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of the chronic use of verapamil, by oral route, in patients with primary dilated cardiomyopathy: a new therapeutic approach?].
    Manfroi WC; Ludwig RT; Vieira SR; Goldim JR; Das SK; de Freitas FM; Faraco EZ
    Arq Bras Cardiol; 1985 Oct; 45(4):293-8. PubMed ID: 3835875
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta-blockade-vasodilator therapy in peripartum cardiomyopathy.
    Chopra A; Chib P; Singh RP; Prabhakaran SN
    J Assoc Physicians India; 1986 Jul; 34(7):532-3. PubMed ID: 3759893
    [No Abstract]   [Full Text] [Related]  

  • 9. [Peripheral vasodilator in cardiac insufficiency in the acute period of myocardial infarction].
    Ruksin VV
    Sov Med; 1985; (2):54-6. PubMed ID: 3992326
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydralazine slow-release: observations on serum profile and clinical efficacy in man.
    Talseth T; Fauchald P; Pape JF
    Curr Ther Res Clin Exp; 1977 Feb; 21(2):157-68. PubMed ID: 403050
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hydralazine in arterial hypertension. Randomized, double-blind comparison between conventional and slow-release preparations].
    Wulff K; Lenz K; Krogsgaard AR; Holst B
    Ugeskr Laeger; 1980 Jul; 142(29):1862-5. PubMed ID: 6996259
    [No Abstract]   [Full Text] [Related]  

  • 12. The long-term survival benefit conferred by intermittent dobutamine infusions and oral amiodarone is greater in patients with idiopathic dilated cardiomyopathy than with ischemic heart disease.
    Tsagalou EP; Anastasiou-Nana MI; Terrovitis JV; Nanas SN; Alexopoulos GP; Kanakakis J; Nanas JN
    Int J Cardiol; 2006 Apr; 108(2):244-50. PubMed ID: 16023232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beta-receptor blockers in dilated cardiomyopathy].
    Osterziel KJ
    Dtsch Med Wochenschr; 1994 Nov; 119(46):1604-5. PubMed ID: 7956807
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of hydralazine on systemic hemodynamics in patients with cardiac insufficiency].
    Koshlia VI
    Klin Med (Mosk); 1985 Oct; 63(10):100-2. PubMed ID: 4079283
    [No Abstract]   [Full Text] [Related]  

  • 15. Afterload reduction for dilated cardiomyopathy.
    Rao PS
    Pediatr Cardiol; 1995; 16(1):51. PubMed ID: 7753706
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of hypertensive patients with adelphan-esidrex].
    Shvedenko LA; Parashchak AP; Ryzhova VL
    Klin Med (Mosk); 1983 Aug; 61(8):24-8. PubMed ID: 6358666
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of the stimulation of H2 receptors by impromidine in patients with idiopathic dilated cardiomyopathy].
    Zoni A; Bonatti V; Albertini R; Scarpignato C; Morozzi L; De Blasi M; Starcich R; Botti G
    Cardiologia; 1987 Sep; 32(9):1035-8. PubMed ID: 2826006
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute haemodynamic effects of terbutaline in congestive cardiomyopathy.
    Gambhir DS; Khalilullah M; Bahl VK
    Indian Heart J; 1986; 38(5):378-83. PubMed ID: 3570323
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydralazine and beta-adrenergic blockade in the treatment of hypertension.
    Siitonen L; Jänne J; Keyriläinen O; Koskinen P; Leskinen O; Pitkäjärvi T; Reinikainen M
    Ann Clin Res; 1974 Dec; 6(6):341-6. PubMed ID: 4155933
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of tensiomin in ischaemic dilatative cardiomyopathy.
    Buzási G; Endresz F; Karády S; Böszörményi E
    Ther Hung; 1993; 41(2):55-9. PubMed ID: 8278939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.